Alkem Laboratories Limited (BOM:539523)

Alkem Laboratories Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	17,329	3,041	4,551	2,738	2,322
Short-Term Investments	32,598	28,983	36,665	7,339	9,424
Trading Asset Securities	-	9,023	1,482	1,355	1,385
Cash & Short-Term Investments	49,927	41,047	42,697	11,432	13,130
Cash Growth	21.63%	-3.86%	273.50%	-12.94%	-25.13%
Accounts Receivable	29,791	25,076	22,855	21,442	18,880
Other Receivables	-	782.1	1,658	1,782	1,607
Receivables	29,857	25,949	24,603	23,292	20,689
Inventory	33,332	29,224	26,612	26,075	30,055
Prepaid Expenses	-	595.3	499.1	443.9	564.4
Other Current Assets	8,988	12,643	9,704	26,054	19,915
Total Current Assets	122,105	109,458	104,116	87,297	84,354
Property, Plant & Equipment	32,285	28,627	25,570	25,135	27,659
Long-Term Investments	23,472	12,988	4,051	5,249	8,803
Goodwill	5,236	4,231	4,167	4,132	4,031
Other Intangible Assets	4,006	1,146	575.8	793.9	721.9
Long-Term Deferred Tax Assets	18,194	17,383	15,148	13,025	13,093
Other Long-Term Assets	3,430	3,078	2,120	1,855	1,950
Total Assets	208,730	176,911	155,749	137,567	140,692

Liabilities

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	22,442	18,394	17,481	11,650	11,734
Accrued Expenses	-	5,073	4,889	9,248	7,941
Short-Term Debt	-	7,349	11,726	13,071	25,706
Current Portion of Long-Term Debt	11,311	169.9	13.4	0.3	1.2
Current Portion of Leases	468.8	506.9	151.8	192	216
Current Income Taxes Payable	665.4	611	549.9	234.4	163.2
Current Unearned Revenue	-	39	39.1	10.5	12.4
Other Current Liabilities	12,941	7,508	5,095	2,665	2,280
Total Current Liabilities	47,827	39,650	39,946	37,072	48,053
Long-Term Debt	4,925	3,109	400	-	93.8
Long-Term Leases	3,768	2,674	1,893	703.3	664.7
Long-Term Unearned Revenue	180.8	219.5	258.4	88	79.2
Pension & Post-Retirement Benefits	-	2,157	1,931	1,702	1,552
Long-Term Deferred Tax Liabilities	151.2	-	-	-	-
Other Long-Term Liabilities	8,389	4,765	4,178	3,652	1,775
Total Liabilities	65,240	52,575	48,605	43,217	52,219

Shareholders' Equity

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	239.1	239.1	239.1	239.1	239.1
Retained Earnings	-	119,603	102,970	90,392	85,811
Comprehensive Income & Other	137,962	7	-88	-178.4	328.5
Total Common Equity	138,201	119,849	103,121	90,453	86,379
Minority Interest	5,288	4,488	4,023	3,897	2,094
Shareholders' Equity	143,489	124,336	107,144	94,350	88,473
Total Liabilities & Equity	208,730	176,911	155,749	137,567	140,692

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	20,472	13,809	14,184	13,967	26,682
Net Cash (Debt)	29,456	27,238	28,513	-2,535	-13,552
Net Cash Growth	8.14%	-4.47%	-	-	-
Net Cash Per Share	246.35	227.81	238.47	-21.20	-113.34
Filing Date Shares Outstanding	119.61	119.57	119.57	119.57	119.57
Total Common Shares Outstanding	119.61	119.57	119.57	119.57	119.57
Working Capital	74,278	69,808	64,170	50,225	36,301
Book Value Per Share	1155.47	1002.37	862.46	756.52	722.44
Tangible Book Value	128,958	114,472	98,377	85,527	81,626
Tangible Book Value Per Share	1078.20	957.40	822.79	715.32	682.69
Land	-	1,245	1,365	1,369	1,373
Buildings	-	9,676	10,226	8,786	9,672
Machinery	-	24,848	23,690	21,710	22,554
Construction In Progress	-	4,766	1,484	3,103	3,395
Leasehold Improvements	-	250.1	107	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error